rufomycin

heptapeptide antibiotic

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Nontuberculous Mycobacterium Infections 01/01/2021 - "Rufomycin Exhibits Dual Effects Against Mycobacterium abscessus Infection by Inducing Host Defense and Antimicrobial Activities."
2.	Inflammation (Inflammations) 01/01/2021 - "In addition, Rufomycin 4-7 significantly decreased inflammation, but enhanced the autophagy/lysosomal genes through upregulation of the nuclear translocation of transcription factor EB (TFEB). "
3.	Infections 01/01/2021 - "Collectively, Rufomycin 4-7-mediated dual effects inducing both antimicrobial activities and host immune defense might confer an advantage to treatment against Mabs-R infection." 01/01/2021 - "Furthermore, Rufomycin 4-7 treatment effectively inhibited mitochondrial damage and oxidative stresses in macrophages during Mabs-R infection. " 01/01/2021 - "Rufomycin 4-7 treatment showed antimicrobial effects against Mabs pulmonary infection in vivo and in macrophages. "

1.	Transcription Factors (Transcription Factor)